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INTRODUCTION
Among the important functions of B cells are antigen reco-
gnition, antigen presentation, antibody production, and im-
mune regulation. The surface markers of B cells include im-
munoglobulin (Ig) M and IgD, which bind antigen, as well
as CD19, CD20 and CD21 (1). Recent results suggest that
the strength of the signal generated through the antigen bind-
ing receptor determines the fate of B cells, that is, whether
they exist as immunoglobulin-secreting B-1 cells or as con-
ventional B-2 cells (2, 3). 
The neck has complicated anatomic structures, with lymph
node influx from the neck itself, the face, the oral cavity, the
upper extremities, the chest, and the abdomen via the thoracic
duct. The neck contains about 30% of the lymphoid tissue
and lymph nodes in the entire body. Consequently, these lym-
phoid structures have a major role as a primary defense bar-
rier against bacteria and other foreign pathogens and against
the spread of malignant tumors. Although the pathology of
lymph nodes has been extensively investigated, there have
been few studies of normal lymph nodes (4, 5). In addition,
little is known about B cells of cervical lymph nodes, perhaps
because these cells are considered identical to all other lym-
phoid B cells and because of the ethical issues involved in
obtaining sufficient cervical lymph nodes of normal individ-
uals. Cervical lymph nodes, however, are exposed to contin-
ual antigenic stimulation from the naso- and/or oro-pharynx.
In the present study, we therefore compared the characteris-
tics of normal murine cervical lymph node B cells with those
of B cells of spleen and peritoneal fluid, which consist of B-
2 and B-1 cells (6-8). 
MATERIALS AND METHODS
Animals
Male BALB/cByJ mice 8-14 week of age were obtained
and housed at least 1 week before experimentation. Mice were
cared for and handled at all times in accordance with institu-
tional animal care committee.
B cell purification and cell count
B cells were obtained from cervical lymph nodes, spleen
and peritoneal fluid. Cell suspensions were depleted of T cells
by treatment with anti-Thy-1.2 antibody plus rabbit com-
plement. They were then plated on plastic dishes to deplete
macrophage. Red blood cells and nonviable cells were remo-
ved by sedimentation over Lympholyte-M (Cedarlane, Ontario,
Canada). The resulting B cells were cultured in Roswell Park
Memorial Institute medium 1640 (BioWhittaker, Walker-
sville, MD, U.S.A.) supplemented with 5% heat-inactivated
fetal bovine serum (Sigma-Aldrich, St. Louis, MO, U.S.A.),
10 mM Hepes (pH7.2) (Calbiochem-Novabiochem, San Di-
ego, CA, U.S.A.), 50  M 2-ME (Sigma-Aldrich), 2 mM L-
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B Cells in Murine Cervical Lymph Nodes are Conventional B-2 Cells
We investigated the characteristic features of cervical lymph node B cells to deter-
mine whether their behavior differs from that of B cells located elsewhere, because
cervical lymph nodes may be exposed to continual antigenic stimulation from the
naso- and/or oropharynx. B cells were isolated from cervical lymph nodes, spleen
and peritoneal fluid of mice, cultured in medium, and exposed to various stimuli. The
expression of various surface molecules characteristic of lymphoid B cells was assay-
ed by flow cytometry, and immunoglobulin secreted into the culture supernatants
was evaluated by enzyme-linked immunosorbent assay. B220+ cells were cultured
in medium alone or with lipopolysaccharide, and their entrance into S phase in res-
ponse to stimuli was measured by proliferative assays. Phenotypic characteristics
of cervical lymph node B cells included CD5
low, CD23
high, CD43
low, B7.1
low, B7.2
low, and
Syndecan-1
low. Unstimulated lymphoid B cells did not secrete immunoglobulin, but,
upon stimulation, secretion of IgM was increased more than secretion of IgA and
IgG. B cells actively entered S phase after 48 hr stimulation. These results show that
B cells in cervical lymph nodes are conventional B2 cells, like splenic B cells.
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glutamine (Invitrogen Co., Japan), 100 U/mL penicillin, and
100  g/mL streptomycin (Invitrogen Co., Japan). 
B cells then were divided into four groups: First, 0.5×10
6
cells for their expression of B cell surface glycoproteins. Sec-
ond, 2.0×10
6 cells for cell survival rate. Third, 2.0×10
6 cells
for the in vitro ELISA assay to measure the amounts of immu-
noglobulin and B cell differentiation. Fourth, 1.0×10
6 cells
for cell proliferation assay to evaluate the entering of S phase. 
Flow cytometry: cell surface staining
Purified B cells or lymphocytes from the cervical lymph
node, spleen and peritoneal fluid were assessed by immunoflu-
oresent staining and flow cytometric analysis (Becton Dickin-
son Corp., Sunnyvale, CA, U.S.A.) to determined the char-
acteristic features of cells. For staining of B cells, B cells were
incubated with fluorescein isothiocyanate (FITC)-conjugat-
ed monoclonal anti-CD220, phycoerythrin (PE)-conjugated
monoclonal antibodies which anti-CD5, anti-CD23, anti-
CD43, anti-CD80 (B7.1), anti-CD86 (B7.2), anti-IgM, or
anti-CD 138 (Syndecan-1) (BD PharMinogen, San Diego,
CA, U.S.A.). 
Survival rate
Cell viability was determined by trypan blue exclusion
(Sigma-Aldrich) and counting cells with a hemocytometer
on days 2 and 5.
Enzyme-linked immunosorbent assay (ELISA) 
Total secreted IgA, IgG and IgM were measured by ELISA.
B cells divided into 4 groups; B cells with medium, B cells
with lipopolysaccharide (LPS), B cells with IL-4 and B cells
with soluble CD40L/ CD8 which is a fusion protein consist-
ing of the extracellular domains of CD40L and CD8 (6), and
collected supernatant at day 1, 2, 3, and 5. The 96 well flat-
bottom trays were coated with each goat anti-mouse Ig (H+L)
(Southern Biotechnology Associates, Inc., Birmingham, AL,
U.S.A.) in coating buffer (Na2CO3 plus NaHCO3 plus NaN3)
and incubated overnight at 4℃. Plates were washed six times.
Applied samples make serial dilutions for standard curve in
PBS/Tween/BSA and followed by 3 hr incubation at room
temperature. After washing, we added horseradish peroxidase-
labeled affinity-purified goat anti-mouse IgM, anti-mouse
IgG, and anti-mouse IgA in PBS/Tween/BSA. After the wash-
ing, a substrate solution, 2,2′ -AZINO-Bis (Sigma-Aldrich)
was added to the wells and plates were read on microplate
reader (Emax, Vienna, Virginia, U.S.A.) at 414 nm. 
Proliferative assay
3×10
4 of B cells were cultured in 0.2 mL in well flat bot-
tomed microtiter plates (Costar, Cambridge, MA, U.S.A.) for
24 hr and 48 hr, at 37℃CO2 incubator, respectively. Tritium
incorporation was assessed after exposure to 0.5  Ci of [
3H]
thymidine (Dupont Co, NEN Research Products, Boston,
MA, U.S.A.) during the last 6 hr of culture. All experimen-
tal and control conditions were carried out in quadruplicate.
Tritium incorporation was measured by MicroBeta Windows
Workstation (1450 Microbeta; Liquid scintillation & Lumi-
nescence counter). Results are reported as mean counts/min
values for quadruplicate cultures; SEM cpm values were
generally less than 10% of mean values.
RESULTS
Surface phenotype
Whole B cells have been classified as B-1 and B-2 cells.
Flow cytometry showed that almost all lymph node B cells
had the B-2 phenotype, which included CD5
low, CD23
high,
CD43
low, CD80 (B7.1)
low, CD86 (B7.2)
low, and Syndecan-1
low,
similar to the phenotype in normal spleen (Fig. 1).
Lymph node B cells do not live longer
Upon stimulation, lymph node B cells showed 60±5.1%
survival on day 2 and 25±3.2% survival on day 5, whereas
unstimulated lymph node B cells showed 39±4.1% and
10±2.3% survival on days 2 and 5, respectively. These sur-
vival rates were no higher than those of splenic and peritoneal
B cells (Fig. 2).
B cells of cervical lymph nodes and spleen secrete
immunoglobulin in response to stimulation
We found that unstimulated B cells from cervical lymph
nodes and spleen did not spontaneously secrete immunoglob-
ulin. These cells secreted IgM upon stimulation with LPS
(3,300 ng/mL on day 3 and 4,286 ng/mL on day 5), CD40L
plus anti-CD8 antibody (1,147 ng/mL on day 3 and 1,392
ng/mL on day 5) or IL-4 (1,017 ng/mL on day 5) (Fig. 3). In
contrast, unstimulated peritoneal B cells secreted IgM, and
secreted higher concentrations of IgM than either splenic or
lymph node B cells (Fig. 4).
Stimulated cervical lymph node and splenic B cells enter
S phase on day 2
Unstimulated B cells of cervical lymph nodes and spleen
did not enter S-phase, as shown by incorporation of [
3H] thy-
midine, after 24 hr in culture, but actively entered S phase
after 48 hr of stimulation. These cells incorporated [
3H] thy-
midine upon stimulation with soluble CD40L/CD8 (229
×10
3±23×10
3 cpm at 24 hr and 3,526×10
3±307×10
3
cpm at 48 hr), LPS (256×10
3±25×10
3 cpm at 24 hr andMurine Cervical Lymph Node B Cells 393
2,790×10
3±254×10
3 cpm at 48 hr), or IL-4 (171×10
3
±18×10
3 cpm at 24 hr and 256×10
3±28×10
3 cpm at
48 hr) (Fig. 5). Although recombinant IL-4 was originally
identified as a growth and differentiation factor for conven-
tional B cells, it did not stimulate cervical lymph node and
splenic B cells to enter S phase. Thus, it seems unlikely that
cervical lymph node B cells are especially primed by antigenic
stimulation to enter the cell cycle.
DISCUSSION
B cells are responsible for antibody-mediated immunity,
which is also known as humoral immunity. These cells are
not evenly distributed in the blood, bone marrow, spleen,
thymus, and peripheral lymphoid tissues. Rather, the ratio
of B cells to T cells varies by the tissue or organ. For example,
human B cells are seldom found in the thymus and, in the
blood, T cells are outnumbered by B cells by a ratio of 8:1.
This ratio changes to 1:1 in the spleen, whereas B cells out-
number T cells by a ratio of 1:3 in bone marrow. We found
that the ratio of B cells to T cells in murine cervical lymph
nodes was 1:3.1 by negative selection methods and 1:2.5 by
flow cytometry (1). 
B cells have been classified as B-1 and B-2 cells. B-1 cells
are distinguished from the more abundant conventional B
(B-2) cells by expression of the pan-T cell surface glycopro-
tein, CD5. Additional identifying phenotypic characteristics
of B-1 cells include surface Ig (sIg) M
high, sIgD
low, B220
low, CD
23
low, and CD43
high. In contrast, B-2 cells express Ig (sIg) M
low,
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Fig. 1. Antigen surface expression on (A) cervical lymph node (B) spleen (C) peritoneal fluid B cells. B cells of BALB/cByJ mice were
harvested and stained with Abs specific for B220, CD5, CD23, CD43, B7.1, B7.2, IgM, and Syndacan-1. Expression of functional molecules
on B cells was analyzed by two-color flow cytometry.
Fig. 2. Survival rates of stimulated and unstimulated B cells. 
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high, B220
high, CD23
high, and CD43
low (3, 9). We found that
cervical lymph node B cells expressed CD5
low, CD23
high, CD
43
low, CD80 (B7.1)
low, CD86 (B7.2)
low and Syndecan-1
low, sug-
gesting that these cells are comparable to B-2 cells. 
We previously reported that splenic B cells are exclusively
B-2 cells and peritoneal B cells are mainly B-1 cells (7). B-1
cells represent 10-25% of the B cells found in adult human
peripheral blood and lymphoid organs. They are the princi-
pal lymphocyte population in the peritoneal cavity and rep-
resent a small proportion of splenic B cells, but they are absent
from the peripheral blood in adult mice (2). Although B-1
(B220
+ CD5
+) cells have been reported to be absent from
murine lymph nodes (10), we found that 3.5% of the B cells
in murine cervical lymph nodes were B220
+ CD5
+ cells (1).
Our phenotypic data, however, represent only a single point
in time, and we cannot rule out the possibility that B-1 cells
are generated in murine cervical lymph nodes and then depart.
When B cells are activated by T-dependent, T cell produc-
ing cytokines or T-independent mitogens, they proliferate or
differentiate into antibody producing plasma cells or mem-
ory cells (11-13). After stimulation with antigen, B cells first
produce IgM and IgD and thereafter switch to secrete IgG,
IgA or IgE, a switching that follows a DNA recombination
event (14). The class of Ig produced by B cells differs by organ
sites, stimuli and/or pathophysiologic conditions. Thus, most
of human B cells in the middle ear and nasal mucosa primari-
ly secrete IgA, both under normal and pathologic conditions,
whereas other B cells in these organs secrete IgG rather than
IgM. In contrast, nasal polyps contain B cells capable of spon-
taneous, high-rate IgA secretion, followed by secretion of
IgG and IgM (15, 16). These findings suggest that the mid-
dle ear mucosa and nasal mucosa contain distinct immune
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Fig. 5. Stimulation of B cell entry into S phase. Primary murine B cells were cultured for 24 hr and 48 hr with medium alone, LPS (25  g/mL),
CD40L (1:10) plus anti-CD8 antibody (1:40), or interleukin (IL)-4 (50 U/mL). [
3H] thymidine was added during the last 6 hr in culture, and
incorporation of label was assessed. Mean values of quadruplicate cultures are shown along with lines indicating the standard errors of
the means.
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Fig. 3. IgM production by murine cervical lymph node B cells. Cells
(0.5×10
6 per group) were cultured in fetal bovine serum (FBS)-
containing culture medium with or without stimulation for 5 days.
Supernatants were collected and assayed for IgM secretion using
an enzyme-linked immunosorbent assay (ELISA).
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Fig. 4. IgM production by peritoneal B cells. Assays were perfor-
med as shown in the legend to Fig. 5.
IgM secretion at day 5
LN
Spleen
Peritoneal cellssystems, which exhibit features similar to those at other mu-
cosal sites. For example, IgG producing adenoid CD5
+ and
CD5
- B cells were most abundant in adenoids, followed by
IgA-producing and IgM-producing cells (17). 
We found that B cells in murine cervical lymph nodes se-
creted mainly IgM, followed by IgG and IgA, when stimu-
lated with LPS, a T-independent mitogen; soluble CD40L/
CD8 , a stimulus provided by T cells; or IL-4, a cytokine
produced by T cells. These finding suggests that B cells in
cervical lymph nodes are stimulated or respond differently
than B cells at the nasal and middle ear mucosal surfaces. In
contrast, our finding, that murine cervical lymph node B cells
do not secrete any Ig spontaneously, was unexpected. This
result suggests that cervical lymph node B cells may not be
subjected to continual antigenic stimulation from the naso-
or oro-pharynx. Rather, it is likely that these cells have the
same characteristic features as splenic B cells. 
There are several differences between B-1 and B-2 cells
concerned with Ig secretion (2, 7). In normal individuals B-1
cells are responsible for the production of most nonimmune
serum IgM, as well as producing substantial amounts of rest-
ing IgA. B-1 cell-derived Ig often recognizes discrete micro-
bial cell wall determinants, suggesting that these cells pro-
duce natural antibodies, representing a set of specificities en-
coded in the germline and evolutionarily retained. These nat-
ural antibodies provide, at low affinity, a degree of serologi-
cal protection against a range of microorganisms prior to the
immunization that accompanies microbial pathogenesis (18).
Primary B cells are normally arrested in the G0 phase of the
cell cycle (6, 7, 19, 20). Following the crosslinking of antigen
specific surface Ig receptors on B cells, a number of early me-
tabolic changes occur, which eventuate in cell cycle progres-
sion and entry into S phase. 
B-1 and B-2 cells also show different proliferation respons-
es. We found that murine cervical lymph node B cells respon-
ded in vitro to LPS or CD40L/CD8 in terms of cell cycle
entry. While they did not proliferate actively after 1 day, they
proliferated at 2 days. We had conjectured that lymph node
B cell would be longer lived than splenic B cells, due to con-
tinuous stimulation from the naso- or oropharynx; however,
their survival rates, with or without stimulation, were not
high, suggesting that murine cervical lymph node B cells have
the characteristics of B-2 cells. 
The phenotypic characteristics of nodal B cells include CD
5
low, CD23
high, CD43
low, B220
high, sIg M
low, sIgD
high, Mac-1
low,
CD80 (B7.1)
low, CD86 (B7.2)
low, and CD138 (Syndecan-1)
low.
Our finding, that 3.5% of B cells were B220
+ CD5
+ suggests
that a small population of B-1 cells is present in cervical lymph
nodes. Unlike our findings with peritoneal B cells, which
spontaneously produce Ig and enter S phase after 1 day of
stimulation, we did not observe these characteristics in cells
from murine cervical lymph nodes. Despite our expectation
that these lymph node B cells would be continually stimu-
lated by antigens from the naso- or oro-pharyngeal mucosa,
we found no evidence for unusual surface phenotype, differ-
entiation, survival rate or proliferation. These results indicate
that cervical lymph node B cells correspond to conventional
B-2 cells and that they have similar characteristics to splenic
B cells (B-2), but not to peritoneal B cells (B-1).
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